Contact
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Press Release
Back to Resources
02/07/2023 | Press Release | PR Newswire
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
Read More
01/31/2023 | Press Release | PR Newswire
PreciseDx Appoints Paul Roma as Chairman of the Board
Read More
01/19/2023 | Press Release | PR Newswire
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
Read More
12/13/2022 | Press Release
PreciseDx to Collaborate with the Champalimaud Foundation to Enhance Current Approaches of Breast Cancer Risk Assessment
Read More
11/29/2022 | Press Release
PreciseDx Announces New Collaboration with Laboratory of Pathology at Dordrecht Albert Schweitzer Hospital
Read More
04/21/2022 | Press Release
PreciseDx’s AI-Enabled Digital Pathology Is the First Proven to Detect Early-Stage Parkinson’s Disease
Read More
03/15/2022 | Press Release
PreciseDx Appoints Life Science Experts, Molly Harper and Eric Converse, to Board of Directors
Read More
01/11/2022 | Press Release
PreciseDx Raises $10.75 Million Series A Preferred from Healthcare Industry Leaders to Commercialize Cancer Risk Stratification Services to Support Better Patient Insights and Outcomes
Read More
< PREVIOUS
1
2
